Jung Hee Lee

US Patent:

6437694, Aug 20, 2002

Filed:

May 1, 2000

Appl. No.:

09/561916

Inventors:

Jung K. Lee - Timonium MD 21093

International Classification:

G08B 1320

US Classification:

340544, 340605, 340606, 340608, 340611

Abstract:

The invention is directed to a system for detecting the presence or absence of a blocker to an air code flow. The system comprises an active air code generator, a sensor element through which an air code generated by the active air code generator travels, and an air code detector, which detects the air code, wherein if the detection of air code by the air code detector is interrupted, it signals the presence or absence of a blocker of the air code.

US Patent:

6562847, May 13, 2003

Filed:

Aug 25, 1999

Appl. No.:

09/383142

Inventors:

Jung S. Lee - Ambler PA

Assignee:

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

International Classification:

H01N 4340

US Classification:

514343, 5462764, 5462681, 546194, 5462784

Abstract:

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O) and R to R are various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimers disease, memory loss or dementia or loss of motor function.

US Patent:

6888001, May 3, 2005

Filed:

Apr 2, 2003

Appl. No.:

10/405250

Inventors:

Jung S. Lee - Ambler PA, US

International Classification:

H01N043/40
C07D401/00

US Classification:

546276, 546268, 546194, 546278, 514343

Abstract:

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O)and Rto Rare various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.

US Patent:

6958349, Oct 25, 2005

Filed:

Mar 31, 2003

Appl. No.:

10/403186

Inventors:

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Assignee:

Ortho-McNeil Pharmaceuticals, Inc. - Raritan NJ

International Classification:

A61K031/47
C07D215/12
C07D215/16

US Classification:

514314, 546174, 546175, 546177

Abstract:

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

US Patent:

7352825, Apr 1, 2008

Filed:

Dec 1, 2003

Appl. No.:

10/725095

Inventors:

Deepak Das - Chatham NJ, US
Jung Ah Lee - Pittstown NJ, US
Shirish Nagaraj - Middletown NJ, US
Anil M. Rao - Hoboken NJ, US

Assignee:

Lucent Technologies Inc. - Murray Hill NJ

International Classification:

H03K 9/00
H03D 1/04

US Classification:

375316, 375346, 375147

Abstract:

The disclosed embodiments relate to a communication system and method. The system may comprise a pre-whitening device that applies pre-whitening data to a received signal from an antenna array to produce a pre-whitened signal, at least one detector that is adapted to recognize a pattern corresponding to a request for access in the pre-whitened signal and compute correlation data corresponding to the pattern, and a threshold detector that determines whether the correlation data exceeds a threshold and indicates that an acknowledgement signal should be transmitted if the threshold is exceeded. The method may comprise the acts of creating a pre-whitened signal by applying pre-whitening data to a received signal, detecting a pattern that corresponds to a request for access in the pre-whitened signal, computing correlation data corresponding to the pattern, determining whether the correlation data exceeds a threshold, and indicating that an acknowledgement signal should be transmitted if the threshold is exceeded.

US Patent:

7358261, Apr 15, 2008

Filed:

Dec 16, 2004

Appl. No.:

11/014471

Inventors:

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Assignee:

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

International Classification:

A61K 31/47
C07D 215/38

US Classification:

514311, 514312, 514314, 546153, 546176, 546178

Abstract:

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

US Patent:

7435822, Oct 14, 2008

Filed:

Feb 2, 2005

Appl. No.:

11/048976

Inventors:

John R. Carson - Norristown PA, US
Jung S. Lee - McLean VA, US

Assignee:

Janssen Pharmaceutica N.V. - Beerse

International Classification:

C07D 401/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00

US Classification:

546125

Abstract:

This invention is directed to 3-(diheteroarylmethylene)-8-azabicyclo[3. 2. 1] octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3. 2. 1] octane derivatives useful as δ-opioid, μ-opioid, or δ-opioid and μ-opioid receptor receptor modulators. Depending on their agonist or antagonist effect, the compounds are useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.

US Patent:

7554952, Jun 30, 2009

Filed:

Feb 9, 2005

Appl. No.:

11/054256

Inventors:

Achilles G. Kogiantis - Madison NJ, US
Jung Ah Lee - Pittstown NJ, US
Lawrence H. Ozarow - Morris Township NJ, US

Assignee:

Alcatel-Lucent USA Inc. - Murray Hill NJ

International Classification:

H04Q 7/00

US Classification:

370334, 370337, 370350, 4554522, 455439

Abstract:

A wireless communication system () includes using multiple antennas () for simultaneous transmissions to multiple mobile stations (). A distributed multiple antenna scheduling (DMAS) technique includes selecting a plurality of mobile stations for at least receiving simultaneous transmissions on at least one selected subcarrier from within a carrier bandwidth having orthogonal frequency division multiplexing (OFDM). In a disclosed example, a plurality of mobile stations are selected for each subcarrier within the carrier bandwidth. A disclosed example includes grouping subcarriers together into subsets to reduce computation complexity for determining which mobile stations to select for the simultaneous transmission.